廣告
香港股市 已收市
  • 恒指

    20,632.30
    +707.72 (+3.55%)
     
  • 國指

    7,299.90
    +213.20 (+3.01%)
     
  • 上證綜指

    3,087.53
    +86.58 (+2.88%)
     
  • 滬深300

    3,703.68
    +158.36 (+4.47%)
     
  • 美元

    7.7721
    -0.0060 (-0.08%)
     
  • 人民幣

    0.9016
    +0.0008 (+0.09%)
     
  • 道指

    42,313.00
    +137.89 (+0.33%)
     
  • 標普 500

    5,738.17
    -7.20 (-0.13%)
     
  • 納指

    18,119.59
    -70.70 (-0.39%)
     
  • 日圓

    0.0544
    +0.0009 (+1.72%)
     
  • 歐元

    8.6752
    -0.0171 (-0.20%)
     
  • 英鎊

    10.3920
    -0.0390 (-0.37%)
     
  • 紐約期油

    68.64
    +0.97 (+1.43%)
     
  • 金價

    2,680.80
    -14.10 (-0.52%)
     
  • Bitcoin

    65,672.88
    +126.11 (+0.19%)
     
  • XRP USD

    0.61
    +0.03 (+4.59%)
     

ResMed Stock Is S&P 500’s Worst Performer. GLP-1 Drugs Are a Risk.

ResMed Stock Is S&P 500’s Worst Performer. GLP-1 Drugs Are a Risk.

Wolfe Research downgraded shares of the maker of sleep-apnea airway machines to Underperform from Peer Perform.